Radiofrequency ablation of breast cancer: first report of an emerging technology.

HYPOTHESIS Radiofrequency (RF) energy applied to breast cancers will result in cancer cell death. DESIGN Prospective nonrandomized interventional trial. SETTING A university hospital tertiary care center. PATIENTS Five women with locally advanced invasive breast cancer, aged 38 to 66 years, who were undergoing surgical resection of their tumor. One patient underwent preoperative chemotherapy and radiation therapy, 3 patients received preoperative chemotherapy, and 1 had no preoperative therapy. All patients completed the study. INTERVENTIONS While patients were under general anesthesia and just before surgical resection, a 15-gauge insulated multiple-needle electrode was inserted into the tumor under sonographic guidance. Radiofrequency energy was applied at a low power by a preset protocol for a period of up to 30 minutes. Only a portion of the tumor was treated to evaluate the zone of RF ablation and the margin between ablated and nonablated tissue. Immediately after RF ablation, the tumor was surgically resected (4 mastectomies, 1 lumpectomy). Pathologic analysis included hematoxylin-eosin staining and enzyme histochemical analysis of cell viability with nicotinamide adenine dinucleotide-diaphorase (NADH-diaphorase) staining of snap-frozen tissue to assess immediate cell death. MAIN OUTCOME MEASURE Cancer cell death as visualized on hematoxylin-eosin-stained paraffin section and NADH-diaphorase cell viability stains. RESULTS There was evidence of cell death in all patients. Hematoxylin-eosin staining showed complete cell death in 2 patients. In 3 patients there was a heterogeneous pattern of necrotic and normal-appearing cells within the ablated tissue. The ablated zone extended around the RF electrode for a diameter of 0.8 to 1.8 cm. NADH-diaphorase cell viability stains of the ablated tissue showed complete cell death in 4 patients. The fifth patient had a single focus of viable cells (<1 mm) partially lining a cyst. There were no perioperative complications related to RF ablation. CONCLUSIONS Intraoperative RF ablation results in invasive breast cancer cell death. Based on this initial report of the use of RF ablation in breast cancer, this technique merits further investigation as a percutaneous minimally invasive modality for the local treatment of breast cancer.

[1]  H. Wilkinson,et al.  Percutaneous radiofrequency upper thoracic sympathectomy. , 1996, Neurosurgery.

[2]  F. Eggerding,et al.  Cryolumpectomy for carcinoma of the breast. , 1987, Surgery, gynecology & obstetrics.

[3]  C C Schulman,et al.  Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. , 1997, Journal of endourology.

[4]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.

[5]  A. Luini,et al.  Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. , 1990, European journal of cancer.

[6]  B Fisher,et al.  Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.

[7]  S. Calderwood,et al.  TEMPERATURE RANGE AND SELECTIVE SENSITIVITY OF TUMORS TO HYPERTHERMIA: A CRITICAL REVIEW , 1980, Annals of the New York Academy of Sciences.

[8]  C. Guilleminault,et al.  Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing. , 1998, Chest.

[9]  R. Swindell,et al.  Radical versus modified radical mastectomy for breast cancer. , 1981, Annals of the Royal College of Surgeons of England.

[10]  L. Organ.  Electrophysiologic principles of radiofrequency lesion making. , 1976, Applied neurophysiology.

[11]  M Paley,et al.  Laser therapy for breast cancer: MR imaging and histopathologic correlation. , 1996, Radiology.

[12]  W. Halsted,et al.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. , 1894, Annals of surgery.

[13]  A. Luini,et al.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. , 1990, Annals of surgery.

[14]  R. Turner,et al.  Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1‐year results of a pilot study , 1996, Annals of neurology.

[15]  A. Zlotta,et al.  Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. , 1998, British journal of urology.

[16]  M. Sabel,et al.  Cryosurgery of breast cancer. , 1997, Archives of surgery.

[17]  Boris Rubinsky,et al.  Transrectal ultrasound‐guided percutaneous radical cryosurgical ablation of the prostate , 1993, Cancer.

[18]  A A Gage,et al.  Cryosurgery in the treatment of cancer. , 1992, Surgery, gynecology & obstetrics.

[19]  C R Hill,et al.  Review article: high intensity focused ultrasound--potential for cancer treatment. , 1995, The British journal of radiology.

[20]  W. Payne,et al.  The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy. , 1976, Mayo Clinic proceedings.

[21]  C. Balch,et al.  A Randomized Prospective Trial of Radical (Halsted) Mastectomy Versus Modified Radical Mastectomy in 311 Breast Cancer Patients , 1983, Annals of surgery.

[22]  B. Fisher.  The evolution of paradigms for the management of breast cancer: a personal perspective. , 1992, Cancer research.

[23]  K. Hynynen,et al.  Development of scanned focussed ultrasound hyperthermia: clinical response evaluation. , 1991, International journal of radiation oncology, biology, physics.

[24]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[25]  H J Mankin,et al.  Percutaneous Radiofrequency Coagulation of Osteoid Osteoma Compared with Operative Treatment* , 1998, The Journal of bone and joint surgery. American volume.

[26]  R. Knobler,et al.  Enzyme histochemical analysis of cell viability after argon laser-induced coagulation necrosis of the skin. , 1991, Journal of the American Academy of Dermatology.

[27]  R. F. Leveen,et al.  Laser hyperthermia and radiofrequency ablation of hepatic lesions , 1997 .

[28]  W. Halsted.  I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. , 1907, Annals of surgery.

[29]  R. Baker,et al.  A Comparison of Modified Radical Mastectomy to Radical Mastectomy in the Treatment of Operable Breast Cancer , 1979, Annals of surgery.

[30]  A S Lichter,et al.  Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  R. Arriagada,et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  Medical and Surgical Uses of Electricity , 1876, Edinburgh Medical Journal.

[33]  S. Schnitt,et al.  Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. , 1986 .

[34]  James Chinn,et al.  Cryosurgery as a treatment for prostate carcinoma , 1997, Cancer.